Literature DB >> 7238997

Theophylline absorption by effervescent activated charcoal (Medicoal).

M Helliwell, D Berry.   

Abstract

Plasma theophylline concentrations were measured in six volunteers given 675 mg of a sustained-release preparation (Phyllocontin). Significant reductions in both the mean recorded peak theophylline plasma concentrations and the mean 12-hour theophylline bioavailability were observed after the administration of effervescent activated charcoal (Medicoal) in single and multiple doses. These results indicate the potential use of activated charcoal in the management of theophylline poisoning.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7238997     DOI: 10.1177/030006058100900313

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  4 in total

Review 1.  Acute overdose with sustained release drug formulations. Perspectives in treatment.

Authors:  A Minocha; D A Spyker
Journal:  Med Toxicol       Date:  1986 Jul-Aug

Review 2.  Clinical pharmacokinetics of oral activated charcoal in acute intoxications.

Authors:  P J Neuvonen
Journal:  Clin Pharmacokinet       Date:  1982 Nov-Dec       Impact factor: 6.447

Review 3.  Role of extracorporeal drug removal in acute theophylline poisoning. A review.

Authors:  A Heath; K Knudsen
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Jul-Aug

4.  Comparison of activated charcoal and ipecac syrup in prevention of drug absorption.

Authors:  P J Neuvonen; M Vartiainen; O Tokola
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.